<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6225461</article-id><article-id pub-id-type="doi">10.3390/molecules23092381</article-id><article-id pub-id-type="publisher-id">molecules-23-02381</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antimycobacterial Activity of Cinnamaldehyde in a <italic>Mycobacterium tuberculosis</italic>(H37Ra) Model</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6593-8484</contrib-id><name><surname>Sawicki</surname><given-names>Rafal</given-names></name><xref ref-type="aff" rid="af1-molecules-23-02381">1</xref><xref rid="c1-molecules-23-02381" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Golus</surname><given-names>Joanna</given-names></name><xref ref-type="aff" rid="af1-molecules-23-02381">1</xref></contrib><contrib contrib-type="author"><name><surname>Przekora</surname><given-names>Agata</given-names></name><xref ref-type="aff" rid="af1-molecules-23-02381">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1108-613X</contrib-id><name><surname>Ludwiczuk</surname><given-names>Agnieszka</given-names></name><xref ref-type="aff" rid="af2-molecules-23-02381">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4773-0329</contrib-id><name><surname>Sieniawska</surname><given-names>Elwira</given-names></name><xref ref-type="aff" rid="af2-molecules-23-02381">2</xref></contrib><contrib contrib-type="author"><name><surname>Ginalska</surname><given-names>Grazyna</given-names></name><xref ref-type="aff" rid="af1-molecules-23-02381">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Carradori</surname><given-names>Simone</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Daglia</surname><given-names>Maria</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Vitalone</surname><given-names>Annabella</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-23-02381"><label>1</label>Chair and Department of Biochemistry and Biotechnology, Medical University of Lublin, Chodzki 1, PL-20093 Lublin, Poland; <email>joanna.golus@umlub.pl</email> (J.G.); <email>agata.przekora@umlub.pl</email> (A.P.); <email>g.ginalska@umlub.pl</email> (G.G.)</aff><aff id="af2-molecules-23-02381"><label>2</label>Medical Plant Unit, Chair and Department of Pharmacognosy, Medical University of Lublin, Chodzki 1, PL-20093 Lublin, Poland; <email>agnieszka.ludwiczuk@umlub.pl</email> (A.L.); <email>elwira.sieniawska@umlub.pl</email> (E.S.)</aff><author-notes><corresp id="c1-molecules-23-02381"><label>*</label>Correspondence: <email>rafal.sawicki@umlub.pl</email>; Tel.: +48-60631-2059</corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2018</year></pub-date><volume>23</volume><issue>9</issue><elocation-id>2381</elocation-id><history><date date-type="received"><day>20</day><month>8</month><year>2018</year></date><date date-type="accepted"><day>16</day><month>9</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The purpose of the study was to evaluate the antimycobacterial activity and the possible action mode of cinnamon bark essential oil and its main constituent&#x02014;cinnamaldehyde&#x02014;against the <italic>Mycobacterium tuberculosis</italic> ATCC 25177 strain. Cinnamaldehyde was proved to be the main bioactive compound responsible for mycobacterial growth inhibition and bactericidal effects. The antimycobacterial activity of cinnamaldehyde was found to be comparable with that of ethambutol, one of the first-line anti-TB antibiotics. The selectivity index determined using cell culture studies in vitro showed a high biological potential of cinnamaldehyde. In <italic>M. tuberculosis</italic> cells exposed to cinnamaldehyde the cell membrane stress sensing and envelope preserving system are activated. Overexpression of <italic>clgR</italic> gene indicates a threat to the stability of the cell membrane and suggests a possible mechanism of action. No synergism was detected with the basic set of antibiotics used in tuberculosis treatment: ethambutol, isoniazid, streptomycin, rifampicin, and ciprofloxacin.</p></abstract><kwd-group><kwd>selectivity index</kwd><kwd>synergy</kwd><kwd>cell membrane</kwd><kwd>stress sensing</kwd><kwd><italic>clgR</italic> expression</kwd></kwd-group></article-meta></front><body><sec id="sec1-molecules-23-02381"><title>1. Introduction</title><p>The political and economic situation, as well as climate changes in many regions of the world, pushing hundreds of thousands of people to leave their homes. This changes the epidemiological situation and facilitates the spread of diseases including tuberculosis (TB). The emergence of multi-and extremely-drug-resistant <italic>Mycobacterium tuberculosis</italic> (Mtb) strains makes TB the global threat. Rifampicin, the last breakthrough drug, was introduced in the 1960s. The limited commercial potential for anti-TB therapies and noticeable withdrawal of pharmaceutical companies from antibacterial drug research make the situation even more disturbing.</p><p>The chemical diversity of natural sources such as essential oils (EO) is one of the areas of search for new promising mycobactericidal substances. Cinnamon essential oil has exhibited antibacterial, antifungal, antiviral, bactericidal, antiparasitics, and larvicidal activities [<xref rid="B1-molecules-23-02381" ref-type="bibr">1</xref>,<xref rid="B2-molecules-23-02381" ref-type="bibr">2</xref>] but little is known about its antimycobacterial characteristic. For antimycobacterial agents searching, the whole-cell screening approach has yielded significant success because it allows screening of all targets at once. The target-based compounds often do not inhibit bacterial growth because of efflux effect or poor penetration. The most challenging of whole-cell screening, however, is an identification of the target and/or action mode of the tested compound [<xref rid="B3-molecules-23-02381" ref-type="bibr">3</xref>].</p><p>The cell membrane of <italic>M. tuberculosis</italic>, apart from other functions, is responsible for stress sensing and adaptive functions. The main mycobacterial envelope and stress signaling system is based on the proteins set composed of MprAB complex cooperating with the accessory sigma factor E (&#x003c3;<sup>E</sup>). Stress dependent MprAB protein misfolding on the extracytoplasmic side of the membrane conduct stress signal by &#x003c3;<sup>E</sup> to the envelope-preserving ClgR-PspA-Rv2743c-Rv2742c system. The transcription factor encoded by clgR gene regulates downstream genes responsible for the cell membrane integrity protection and energy generation under stress. Except that, the ClgR controlled genes complex is necessary for MprAB-&#x003c3;E stress-signalling activity. This positive feedback between preserving and envelope-stress-sensing functions helps to respond to a number of cell membrane-perturbing signals during tuberculosis pathogenesis. The clgR-pspA-rv2743c-rv2742c genes set is conserved only within the <italic>M.&#x02009;tuberculosis</italic> complex consisting of <italic>M. tuberculosis</italic>, <italic>M. bovis</italic>, <italic>M. africanum</italic>, <italic>M. canettii</italic> and <italic>M. orygis</italic> [<xref rid="B4-molecules-23-02381" ref-type="bibr">4</xref>,<xref rid="B5-molecules-23-02381" ref-type="bibr">5</xref>,<xref rid="B6-molecules-23-02381" ref-type="bibr">6</xref>].</p><p>The aim of the work was to determine the MIC and MBC values for cinnamaldehyde and cinnamon essential oil and evaluate the possible synergy of the tested substances with the panel of antibiotics currently used in the treatment of tuberculosis. Expression profile of clgR gene after exposure of <italic>M. tuberculosis</italic> to cinnamaldehyde shed light on its mode of action. The African green monkey kidney epithelial cells (GMK) were used for the selectivity index (SI) evaluation for both samples in cell culture studies in vitro.</p></sec><sec id="sec2-molecules-23-02381"><title>2. Results and Discussion</title><p>The composition of the <italic>Cinnamomumverum</italic> bark essential oil was verified by GC/MS analysis and proved to be typical for this species. The most abundant compounds were cinnamaldehyde (75%), eugenol (7.5%), linalool (6.0%), &#x003b2;-caryophyllene (4.0%) and 1,8-cineole (6%). To investigate antimycobacterial properties of cinnamon EO and its main components: cinnamaldehyde, eugenol and linalool, MIC values were determined. The front-line (or primary) anti-TB drugs were used as positive control (<xref rid="molecules-23-02381-t001" ref-type="table">Table 1</xref>). Determined MIC values for antibiotics were in general agreement with literature data for <italic>M. tuberculosis</italic> H37Ra strain [<xref rid="B7-molecules-23-02381" ref-type="bibr">7</xref>].</p><p>Antibiotics used in MIC evaluation belong to the most important and effective medicines we have in the fight against mycobacteria. Because of this most of them have low or very low MIC values against fragile <italic>M. tuberculosiss</italic> trains like the H37Ra strain. Antimycobacterial activity of cinnamon EO and cinnamaldehyde was found to be one serial dilution higher than MIC for ethambutol. The same MIC for both substances and high MIC values for the next two most abundant compouds: eugenol and linalool indicate that the main constituent of cinnamon essential oil is responsible for anti-TB properties. Other authors have reported the following MIC values for cinnamaldehyde: 3.12 &#x000b5;g/mL (<italic>M. tuberculosis</italic> H37Rv), 12.5 &#x000b5;g/mL (<italic>M. bovis</italic> AN5), 24 &#x000b5;g/mL (<italic>M. aviumsubsp.paratuberculosis</italic>) [<xref rid="B8-molecules-23-02381" ref-type="bibr">8</xref>,<xref rid="B9-molecules-23-02381" ref-type="bibr">9</xref>]. This may suggest more universal antimycobacterial properties of cinnamaldehyde within <italic>Mycobacterium</italic> genus.</p><p>To differentiate between inhibiting and killing abilities of cinnamon oil and cinnamaldehyde, the MBC was determined. Both tested compounds showed the MBC equal to 32 &#x003bc;g/mL. To consider the compound bactericidal activity, MBC/MIC ratio must be less than or equal to 4. The calculated value was 4, what proved their strong bactericidal properties.</p><p>The same substances were examined for eventual synergism with primary anti-TB drugs. Fraction inhibitory concentration index (FIC<sub>I</sub>) was equal to 2 for all combinations, except cinnamon EO and streptomycin where FIC<sub>I</sub> was equal to 1, therefore no synergism effect was confirmed.</p><p>To evaluate the possible cytotoxicity of cinnamaldehyde and cinnamon EO safety index (SI) was determined. Within these studies, it was demonstrated that tested natural agents only slightly reduced the viability of eukaryotic epithelial cells (GMK, also known as Vero line) after 24 h exposure. It was found that cinnamon EO and cinnamaldehyde exerted low cytotoxic effect against GMK cells and revealed significant antimycobacterial activity. Cinnamaldehyde showed significantly less cytotoxic effect than cinnamon EO and thus was characterized by higher SI value. Since promising antibacterial agents should have SI &#x0003e; 10, it may be inferred that cinnamaldehyde has a high biomedical potential to be used as the antimycobacterial agent (<xref rid="molecules-23-02381-t002" ref-type="table">Table 2</xref>).</p><p>Other authors also identified a high biomedical potential of <italic>C. verum</italic> EO. Azeredoet al. demonstrated that <italic>C. verum</italic> EO revealed high activity against <italic>Trypanosomacruzi</italic> (epimastigotes, trypomastigotes, and amastigotes) and hindered the differentiation process of parasites in vitro. Similarly to our results, they also demonstrated slight cytotoxic effect of cinnamon EO against Vero cell line (green monkey kidney epithelial cells)&#x02014;IC<sub>50</sub> = 49.4 &#x000b1; 1.12 &#x003bc;g/mL after 24 h exposure [<xref rid="B2-molecules-23-02381" ref-type="bibr">2</xref>]. Whereas, Choi et al. showed relevant antibacterial activity of <italic>C. verum</italic> EO against <italic>Streptococcus mutans</italic> and <italic>Streptococcus sobrinus</italic> [<xref rid="B10-molecules-23-02381" ref-type="bibr">10</xref>].</p><p>The harmful effect on cell wall and cell membrane is often used as an explanation of the antimicrobial mode of action of essential oils. For example, monoterpenes are able to function as impurities in phospholipid bilayer and introduce chaos in usually ordered structure. Since mycobacterial cell wall is lipophilic, essential oils components can easily interact with cell envelope [<xref rid="B11-molecules-23-02381" ref-type="bibr">11</xref>]. Now Otarska et al. proved that exposure <italic>M. aviumsubsp.paratuberculosis</italic> to cinnamaldehyde could modify cell membrane causing the leakage of phosphate and other essential cell components and ultimately the death of cells [<xref rid="B9-molecules-23-02381" ref-type="bibr">9</xref>].</p><p>The clgR gene expression was used as the marker of stress sensing/envelope preserving system status. <italic>M. tuberculosis</italic> exposed to the cell membrane stress agent activates two positive-feedback loops: MprAB-&#x003c3;E and &#x003c3;E-ClgR. The clgR gene encodes transcriptional factor integrating MprAB stress sensing with the envelope preserving ClgR-PspA-Rv2743c-Rv2742c system through the sigma factor &#x003c3;E [<xref rid="B4-molecules-23-02381" ref-type="bibr">4</xref>]. The observed overexpression of clgR gene proves that cinnamaldehyde penetrated the thick mycobacterial cell wall and interacted with the cell membrane and/or membrane proteins (<xref ref-type="fig" rid="molecules-23-02381-f001">Figure 1</xref>). This finding confirmed the possible mode of action that is associated with destabilization of the mycobacterial cell membrane [<xref rid="B12-molecules-23-02381" ref-type="bibr">12</xref>].</p><p>Concluding, cinnamaldehyde the main and active compound of <italic>Cinnamomumverum</italic> bark essential oil has high inhibitoryand the killing potential for <italic>Mycobacterium tuberculosis</italic> H37Ra. High SI index for this compound confirms its biomedical potential as the antimycobacterial agent. The <italic>clgR</italic> gene expression profile proves that cinnamaldehyde threatens the membrane integrity and activates stress response system. The antibiotics used in the experiment were extremely different in their mode of action but neither synergism nor antagonism was detected between tested natural agents and primary anti-TB drugs. Although cinnamaldehyde probably changes cell membrane stability/permeability it did not facilitate the action even of intracellular antibiotics like streptomycin or rifampicin. Because of its antimycobacterial properties cinnamaldehyde can be used as a starting point for the new drugs design [<xref rid="B13-molecules-23-02381" ref-type="bibr">13</xref>,<xref rid="B14-molecules-23-02381" ref-type="bibr">14</xref>].</p></sec><sec id="sec3-molecules-23-02381"><title>3. Materials and Methods</title><sec id="sec3dot1-molecules-23-02381"><title>3.1. Cinnamon Bark Oil-GC/MS Analysis</title><p><italic>Cinnamomumverum</italic> bark essential oil was obtained from Unimark Remedies Ltd. (Mumbai, India). GC-MS was performed with a GC-2010 Plus gas chromatography instrument (Shimadzu Kioto, Japan) coupled to a Shimadzu QP2010 Ultra mass spectrometer. Compounds were separated on a fused silica capillary column ZB-5 MS (30 m, 0.25 mmi.d.) with a film thickness of 0.25 &#x003bc;m (Phenomenex, Torrance, CA, USA). Compounds were identified using a computer-supported spectral library [<xref rid="B15-molecules-23-02381" ref-type="bibr">15</xref>,<xref rid="B16-molecules-23-02381" ref-type="bibr">16</xref>], mass spectra of reference compounds, as well as MS data from the literature [<xref rid="B17-molecules-23-02381" ref-type="bibr">17</xref>,<xref rid="B18-molecules-23-02381" ref-type="bibr">18</xref>]. The identities were confirmed by comparison of retention indices with reference compounds and published data.</p></sec><sec id="sec3dot2-molecules-23-02381"><title>3.2. Inoculum Preparation</title><p><italic>M. tuberculosis</italic> H37Ra ATCC 25177 was grown on L&#x000f6;wenstein-Jensen slopes (BioMaxima, Lublin, Poland) for two weeks. Bacterial mass was transferred to 7H9-S medium (Middlebrook 7H9 broth supplemented with 10% ADC-albumin dextrose catalase and 0.2% glycerol; (Becton Dickinson, Franklin Lakes, NJ, USA) and vortexed with glass beads. After 30 min of incubation for lager clumps sedimentation, upper phase was transferred to a sterile tube and left for 15 min. Next, supernatant was placed in a fresh tube and was adjusted to 0.5 McFarland standard with 7H9-S broth. The final density of inoculum in each well was approx. 5 &#x000d7; 10<sup>5</sup> CFU/mL.</p></sec><sec id="sec3dot3-molecules-23-02381"><title>3.3. MIC Determination</title><p><italic>Cinnamomumverum</italic> essential oil, cinnamaldehyde, eugenol, and linalool (reference standards), (Sigma-Aldrich, Saint Lois, MO, USA) were tested in the concentration range from 256 to 2 &#x000b5;g/mL. Serial twofold dilutions were prepared in dimethyl sulphoxide (DMSO; Sigma-Aldrich) using 7H9-Smedium as dilution. The final DMSO concentration did not exceed 1% (<italic>v</italic>/<italic>v</italic>) and had no influence on growth of the tested strain.</p><p>Isoniazid, ethambutol, rifampicin, streptomycin and ciprofloxacin (Sigma-Aldrich) were used as reference standards. Stock solutions were prepared according to the manufacturer&#x02019;s instructions. Final twofold dilutions from 16 to 0.001 &#x003bc;g/mL were prepared in 7H9-Sbroth.</p><p>The round bottom microwell plates were prepared as follows: 50 &#x003bc;L of inoculum and 50 &#x003bc;L of tested substances were added to each well. The sterility, growth and 1% DMSO controls were included. The plates were closed with sealing foil to prevent liquid evaporation and incubated for 8 days at 37 &#x000b0;C. After incubation, 10 &#x000b5;L of resazurin (AlamarBlue, Invitrogen, Carlsbad, CA, USA) solution were added to each well, incubated for 48 h at 37 &#x000b0;C, and assessed for color development. The MIC was defined as the lowest drug concentration that prevented blue to pink color change [<xref rid="B19-molecules-23-02381" ref-type="bibr">19</xref>]. The MIC determination was repeated in three independent experiments. Since the obtained results were identical, no statistical method was applied.</p></sec><sec id="sec3dot4-molecules-23-02381"><title>3.4. MBC Determination</title><p>Minimal bactericidal concentrations (MBCs) of <italic>C. verum</italic> essential oil and cinnamaldehyde against <italic>M. tuberculosis</italic> H37Ra were determined according to the CLSI method [<xref rid="B20-molecules-23-02381" ref-type="bibr">20</xref>] considering longer time of <italic>mycobacterium</italic> incubation. After 8 days of incubation (inoculum and plates were prepared analogically to MIC assay), mycobacterium cultures were spread on agar plates (Middlebrook 7H10 agar supplemented with 10% OADC-oleic albumin dextrose catalase and 0.5% glycerol) and incubated for 4 weeks at 37 &#x000b0;C. MBC was defined as a compound concentration with at least a 3 log reduction of CFU compared to the initial CFU.</p></sec><sec id="sec3dot5-molecules-23-02381"><title>3.5. Checkerboard Assay</title><p>Synergistic interactions between <italic>C. verum</italic> EO/cinnamaldehyde and antibiotics: ethambutol (EMB), isoniazid (INH), streptomycin (SM), rifampicin (RMP), and ciprofloxacin (CIP) were examined by the checkerboard test based on resazurin assay similarly as MIC determination. The fractional inhibitory concentration index (FIC<sub>I</sub>) was calculated for each combination of two agents concentrations according to the following formula:<disp-formula>FIC<sub>I</sub> = (MIC<sub>A/B</sub>/MIC<sub>A</sub>) + (MIC<sub>B/A</sub>/MIC<sub>B</sub>)</disp-formula>
where MIC<sub>A</sub> = MIC of the compound A alone, MIC<sub>A/B</sub> is the MIC of compound A in combination with compound B and MIC<sub>B</sub>, MIC<sub>B/A</sub> is defined analogously as compound A.</p><p>Total synergism (FIC<sub>I</sub> &#x02264; 0.5), partial synergism (0.5 &#x0003c; FIC<sub>I</sub> &#x02264; 0.75), no effect (0.75 &#x0003c; FIC<sub>I</sub> &#x02264; 2) or antagonism (FIC<sub>I</sub> &#x0003e; 2) between two compounds were deduced from the values of the FIC<sub>I</sub> [<xref rid="B21-molecules-23-02381" ref-type="bibr">21</xref>,<xref rid="B22-molecules-23-02381" ref-type="bibr">22</xref>].</p></sec><sec id="sec3dot6-molecules-23-02381"><title>3.6. Cell Culture Studies In Vitro</title><p>An experiment was carried out using African green monkey kidney epithelial cells (GMK) obtained from BIOMED-Lublin S.A. (Lublin, Poland). To assess the cytotoxicity of the tested agents, the GMK cells were seeded in 96-multiwell plates at a concentration of 3 &#x000d7; 10<sup>4</sup> cells/well (in 100 &#x003bc;L of the complete culture medium) and the plates were maintained at 37 &#x000b0;C for 24 h. Then, the culture medium was discarded and replaced with 100 &#x000b5;L of culture medium containing different concentrations of cinnamon EO, cinnamaldehyde, and a reference antimycobacterial drug-rifampicin. The compounds were tested at 9 different concentrations (in the range 500&#x02013;1.95 &#x000b5;g/mL). After 24 h exposure to the tested compounds and reference drug, viability of GMK cells was assessed using MTT assay (Sigma-Aldrich) as described earlier [<xref rid="B23-molecules-23-02381" ref-type="bibr">23</xref>]. The test was carried out in 3 independent experiments (<italic>n</italic> = 3) and performed in octuplicate. The IC<sub>50</sub> values (concentration reducing cell viability by 50%) were determined using GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA). Based on obtained MIC values against <italic>M. tuberculosis</italic> H37Ra and IC<sub>50</sub> determined using GMK cells, the selectivity index (SI) in vitro was calculated using the following formula: <disp-formula>SI = IC<sub>50</sub>/MIC.</disp-formula></p></sec><sec id="sec3dot7-molecules-23-02381"><title>3.7. Exposure to Cinnamaldehyde</title><p>Freshly prepared 50 mL of 7H9-S were inoculated with 1 mL of <italic>M. tuberculosis</italic> H37Ra of 1 McFarland standard. Bacteria were incubated at 37 &#x000b0;C with gentle aeration (100 RPM) for three weeks. Then, 8 mL of culture were moved to a fresh tube and exposed for 1 h to 512 &#x000b5;g/mL cinnamaldehyde (value determined by resazurin assay for the short 1-h exposure for late log-phase of mycobacterial culture). Culture without tested compound supplementation (8 mL) was used as expression level control. As the positive control, additional 8 mL of culture supplemented with SDS (final concentration 0.03% (300 &#x000b5;g/mL)) were added and samples were incubated for 1 h accordingly to the elegant experiment described by Datta at all. [<xref rid="B4-molecules-23-02381" ref-type="bibr">4</xref>]. After incubation, tubes were centrifuged and total mycobacterial RNA was isolated.</p><sec id="sec3dot7dot1-molecules-23-02381"><title>3.7.1. Total RNA Preparation</title><p>Total RNA isolation was performed with Fast RNA Pro Blue Kit (MP Biomedicals, Santa Ana, CA, USA) according to manufacturer&#x02019;s instructions. Cells were disrupted in a bead-beater FastPrep24 ((MP Biomedicals, Santa Ana, CA, USA). Possible RNA contamination with genomic DNA was eliminated with deoxyribonuclease I (Sigma-Aldrich) according to manufacturer&#x02019;s manual. The RNA concentration and purity were measured spectrophotometrically, aliquoted and stored at &#x02212;80 &#x000b0;C for further use.</p></sec><sec id="sec3dot7dot2-molecules-23-02381"><title>3.7.2. qPCRReaction</title><p>All quantitative PCR (qPCR) reactions ware done with LightCycler<sup>&#x000ae;</sup> EvoScript RNA SYBR<sup>&#x000ae;</sup> Green I Master kit (Roche, Penzberg, Germany) in LightCycler<sup>&#x000ae;</sup> 480 thermal cycler (Roche) in total volume of 20 &#x003bc;L per reaction on 96 (Roche, Penzberg, Germany). Reactions were managed with automatic pipetting station epMotion 5070 (Eppendorf, Hamburg, Germany).</p><p>The PCR efficiency was measured for each pair of primers used inexperiments. For relative quantification of transcript levels, target gene was normalized to the housekeeping gene <italic>sigA.</italic> The <italic>clgR</italic> primers (fwd5&#x02032;AGCTGCAGAGCCGTACAAAT3&#x02032;, rev 5&#x02032;CCTCGGGTATCTGTCGGAGA3&#x02032;, calculated efficiency 2.02) and <italic>sigA</italic> (fwd5&#x02032;GACGAAGACCACGAAGAC3&#x02032;, rev 5&#x02032;TCATCCCAGACGAAATCAC3&#x02032;, calculated efficiency 1.98) were synthesized by Sigma-Aldrich. Relative quantification was calculated according to Pfaffl mathematical model [<xref rid="B24-molecules-23-02381" ref-type="bibr">24</xref>]. The test was carried out in 2 independent experiments and performed in triplicate.</p></sec></sec></sec></body><back><fn-group><fn><p><bold>Sample Availability:</bold> Samples of the compounds are available from the authors.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, R.S.; Methodology, R.S., J.G.; Validation, J.G. and R.S.; Investigation, R.S., J.G., A.P. and A.L.; Data Curation, R.S.; Writing&#x02014;Original Draft Preparation, R.S.; Funding Acquisition, E.S. and G.G.</p></notes><notes><title>Funding</title><p>This work was financially supported by the Polish National Science Centre [grant No. 2013/11/D/NZ7/01613]; The Ministry of Science and Higher Education in Poland [within the DS2 project of the Medical University of Lublin]; and Operational Program Development of Eastern Poland 2007&#x02013;2013 [the equipment purchased within the Agreement no. POPW.01.03.00-06-010/09-00, Priority Axis I, Modern Economy, Operations 1.3. Innovations and Promotion].</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-23-02381"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>A.Y.</given-names></name><name><surname>Foster</surname><given-names>S.</given-names></name></person-group><source>Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics</source><publisher-name>Wiley</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1996</year><volume>Volume 38</volume><fpage>365</fpage></element-citation></ref><ref id="B2-molecules-23-02381"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azeredo</surname><given-names>C.M.O.</given-names></name><name><surname>Santos</surname><given-names>T.G.</given-names></name><name><surname>Maia</surname><given-names>B.H.L.D.S.</given-names></name><name><surname>Soares</surname><given-names>M.J.</given-names></name></person-group><article-title>In vitro biological evaluation of eight different essential oils against <italic>Trypanosomacruzi</italic>, with emphasis on <italic>Cinnamomum verum</italic> essential oil</article-title><source>BMC Complement. Altern. Med.</source><year>2014</year><volume>14</volume><elocation-id>309</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-14-309</pub-id><?supplied-pmid 25148924?><pub-id pub-id-type="pmid">25148924</pub-id></element-citation></ref><ref id="B3-molecules-23-02381"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mdluli</surname><given-names>K.</given-names></name><name><surname>Kaneko</surname><given-names>T.</given-names></name><name><surname>Upton</surname><given-names>A.</given-names></name></person-group><article-title>Tuberculosis drug discovery and emerging targets</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2014</year><volume>1323</volume><fpage>56</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1111/nyas.12459</pub-id><?supplied-pmid 24920100?><pub-id pub-id-type="pmid">24920100</pub-id></element-citation></ref><ref id="B4-molecules-23-02381"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>P.</given-names></name><name><surname>Ravi</surname><given-names>J.</given-names></name><name><surname>Guerrini</surname><given-names>V.</given-names></name><name><surname>Chauhan</surname><given-names>R.</given-names></name><name><surname>Neiditch</surname><given-names>M.B.</given-names></name><name><surname>Shell</surname><given-names>S.S.</given-names></name><name><surname>Fortune</surname><given-names>S.M.</given-names></name><name><surname>Hancioglu</surname><given-names>B.</given-names></name><name><surname>Igoshin</surname><given-names>O.A.</given-names></name><name><surname>Gennaro</surname><given-names>M.L.</given-names></name></person-group><article-title>The Psp system of <italic>Mycobacterium tuberculosis</italic> integrates envelope stress-sensing and envelope-preserving functions</article-title><source>Mol. Microbiol.</source><year>2015</year><volume>97</volume><fpage>408</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1111/mmi.13037</pub-id><?supplied-pmid 25899163?><pub-id pub-id-type="pmid">25899163</pub-id></element-citation></ref><ref id="B5-molecules-23-02381"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manganelli</surname><given-names>R.</given-names></name><name><surname>Provvedi</surname><given-names>R.</given-names></name></person-group><article-title>An integrated regulatory network including two positive feedback loops to modulate the activity of sigma(E) in mycobacteria</article-title><source>Mol. Microbiol.</source><year>2010</year><volume>75</volume><fpage>538</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.07009.x</pub-id><?supplied-pmid 20025668?><pub-id pub-id-type="pmid">20025668</pub-id></element-citation></ref><ref id="B6-molecules-23-02381"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bretl</surname><given-names>D.J.</given-names></name><name><surname>Bigley</surname><given-names>T.M.</given-names></name><name><surname>Terhune</surname><given-names>S.S.</given-names></name><name><surname>Zahrt</surname><given-names>T.C.</given-names></name></person-group><article-title>The MprBExtracytoplasmic Domain Negatively Regulates Activation of the <italic>Mycobacterium tuberculosis</italic> MprAB Two-Component System</article-title><source>J. Bacteriol.</source><year>2014</year><volume>196</volume><fpage>391</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1128/JB.01064-13</pub-id><?supplied-pmid 24187094?><pub-id pub-id-type="pmid">24187094</pub-id></element-citation></ref><ref id="B7-molecules-23-02381"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrichs</surname><given-names>M.</given-names></name><name><surname>May</surname><given-names>R.</given-names></name><name><surname>Heider</surname><given-names>F.</given-names></name><name><surname>Reimers</surname><given-names>T.</given-names></name><name><surname>Sy</surname><given-names>S.B.</given-names></name><name><surname>Peloquin</surname><given-names>C.</given-names></name><name><surname>Derendorf</surname><given-names>H.</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> Strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs</article-title><source>Int. J. Mycobacteriol.</source><year>2018</year><volume>7</volume><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.4103/ijmy.ijmy_33_18</pub-id><?supplied-pmid 29900893?><pub-id pub-id-type="pmid">29900893</pub-id></element-citation></ref><ref id="B8-molecules-23-02381"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Ochoa</surname><given-names>S.</given-names></name><name><surname>Nevarez-Moorillon</surname><given-names>G.V.</given-names></name><name><surname>Sanchez-Torres</surname><given-names>L.E.</given-names></name><name><surname>Villanueva-Garcia</surname><given-names>M.</given-names></name><name><surname>Sanchez-Ramirez</surname><given-names>B.E.</given-names></name><name><surname>Rodriguez-Valdez</surname><given-names>L.M.</given-names></name><name><surname>Rivera-Chavira</surname><given-names>B.E.</given-names></name></person-group><article-title>Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against <italic>Mycobacterium tuberculosis</italic> and <italic>Mycobacterium bovis</italic></article-title><source>BMC Complement. Altern. Med.</source><year>2015</year><volume>15</volume><elocation-id>332</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-015-0858-2</pub-id><?supplied-pmid 26400221?><pub-id pub-id-type="pmid">26400221</pub-id></element-citation></ref><ref id="B9-molecules-23-02381"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowotarska</surname><given-names>S.</given-names></name><name><surname>Nowotarski</surname><given-names>K.</given-names></name><name><surname>Grant</surname><given-names>I.</given-names></name><name><surname>Elliott</surname><given-names>C.</given-names></name><name><surname>Friedman</surname><given-names>M.</given-names></name><name><surname>Situ</surname><given-names>C.</given-names></name></person-group><article-title>Mechanisms of Antimicrobial Action of Cinnamon and Oregano Oils, Cinnamaldehyde, Carvacrol, 2,5-Dihydroxybenzaldehyde, and 2-Hydroxy-5-Methoxybenzaldehyde against <italic>Mycobacterium avium</italic> subsp. paratuberculosis (Map)</article-title><source>Foods</source><year>2017</year><volume>6</volume><elocation-id>72</elocation-id><pub-id pub-id-type="doi">10.3390/foods6090072</pub-id><?supplied-pmid 28837070?><pub-id pub-id-type="pmid">28837070</pub-id></element-citation></ref><ref id="B10-molecules-23-02381"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>O.</given-names></name><name><surname>Cho</surname><given-names>S.K.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Park</surname><given-names>C.G.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name></person-group><article-title>In vitro antibacterial activity and major bioactive components of <italic>Cinnamomum verum</italic> essential oils against cariogenic bacteria, Streptococcus mutans and Streptococcus sobrinus</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2016</year><volume>6</volume><fpage>308</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2016.01.007</pub-id></element-citation></ref><ref id="B11-molecules-23-02381"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trombetta</surname><given-names>D.</given-names></name><name><surname>Castelli</surname><given-names>F.</given-names></name><name><surname>Sarpietro</surname><given-names>M.G.</given-names></name><name><surname>Venuti</surname><given-names>V.</given-names></name><name><surname>Cristani</surname><given-names>M.</given-names></name><name><surname>Daniele</surname><given-names>C.</given-names></name><name><surname>Saija</surname><given-names>A.</given-names></name><name><surname>Mazzanti</surname><given-names>G.</given-names></name><name><surname>Bisignano</surname><given-names>G.</given-names></name></person-group><article-title>Mechanisms of antibacterial action of three monoterpenes</article-title><source>Antimicrob. Agents Chmother.</source><year>2005</year><volume>49</volume><fpage>2474</fpage><lpage>2478</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.6.2474-2478.2005</pub-id><?supplied-pmid 15917549?><pub-id pub-id-type="pmid">15917549</pub-id></element-citation></ref><ref id="B12-molecules-23-02381"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawicki</surname><given-names>R.</given-names></name><name><surname>Sieniawska</surname><given-names>E.</given-names></name><name><surname>Swatko-Ossor</surname><given-names>M.</given-names></name><name><surname>Golus</surname><given-names>J.</given-names></name><name><surname>Ginalska</surname><given-names>G.</given-names></name></person-group><article-title>The frequently occurring components of essential oils beta elemene and R-limonene alter expression of dprE1 and clgR genes of <italic>Mycobacterium tuberculosis</italic> H37Ra</article-title><source>Food Chem. Toxicol.</source><year>2018</year><volume>112</volume><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2017.12.052</pub-id><?supplied-pmid 29288759?><pub-id pub-id-type="pmid">29288759</pub-id></element-citation></ref><ref id="B13-molecules-23-02381"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polaquini</surname><given-names>C.R.</given-names></name><name><surname>Torrezan</surname><given-names>G.S.</given-names></name><name><surname>Santos</surname><given-names>V.R.</given-names></name><name><surname>Nazare</surname><given-names>A.C.</given-names></name><name><surname>Campos</surname><given-names>D.L.</given-names></name><name><surname>Almeida</surname><given-names>L.A.</given-names></name><name><surname>Silva</surname><given-names>I.C.</given-names></name><name><surname>Ferreira</surname><given-names>H.</given-names></name><name><surname>Pavan</surname><given-names>F.R.</given-names></name><name><surname>Duque</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Antibacterial and Antitubercular Activities of Cinnamylideneacetophenones</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1685</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22101685</pub-id><?supplied-pmid 28994740?><pub-id pub-id-type="pmid">28994740</pub-id></element-citation></ref><ref id="B14-molecules-23-02381"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaral</surname><given-names>T.C.</given-names></name><name><surname>Miguel</surname><given-names>F.B.</given-names></name><name><surname>Couri</surname><given-names>M.R.C.</given-names></name><name><surname>Corbi</surname><given-names>P.P.</given-names></name><name><surname>Carvalho</surname><given-names>M.A.</given-names></name><name><surname>Campos</surname><given-names>D.L.</given-names></name><name><surname>Pavan</surname><given-names>F.R.</given-names></name><name><surname>Cuin</surname><given-names>A.</given-names></name></person-group><article-title>Silver(I) and zinc(II) complexes with symmetrical cinnamaldehyde Schiff base derivative: Spectroscopic, powder diffraction characterization, and antimycobacterial studies</article-title><source>Polyhedron</source><year>2018</year><volume>146</volume><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.poly.2018.02.024</pub-id></element-citation></ref><ref id="B15-molecules-23-02381"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Hochmuth</surname><given-names>D.H.</given-names></name></person-group><source>Consulting, MassFinder</source><publisher-name>Dr Hochmuth Scientific Consulting</publisher-name><publisher-loc>Hamburg, Germany</publisher-loc><year>2008</year></element-citation></ref><ref id="B16-molecules-23-02381"><label>16.</label><element-citation publication-type="book"><source>Technology, NIST/EPA/NIH Mass Spectral Library</source><comment>PC Version 1.7.</comment><publisher-name>Perkin Elmer Corp.</publisher-name><publisher-loc>Norwalk, CT, USA</publisher-loc><year>1999</year></element-citation></ref><ref id="B17-molecules-23-02381"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Joulain</surname><given-names>D.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>W.A.</given-names></name></person-group><source>The Atlas of Spectral Data of Sesquiterpene Hydrocarbons</source><publisher-name>E.B.-Verlag</publisher-name><publisher-loc>Hamburg, Germany</publisher-loc><year>1998</year></element-citation></ref><ref id="B18-molecules-23-02381"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>NIST Technology</collab></person-group><source>NIST Chemistry Webbook: NIST Standard Reference Database Number 69</source><comment>Standards</comment><publisher-name>NIST Technology</publisher-name><publisher-loc>Gaithersburg, MD, USA</publisher-loc><year>2011</year></element-citation></ref><ref id="B19-molecules-23-02381"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palomino</surname><given-names>J.C.</given-names></name><name><surname>Martin</surname><given-names>A.</given-names></name><name><surname>Camacho</surname><given-names>M.</given-names></name><name><surname>Guerra</surname><given-names>H.</given-names></name><name><surname>Swings</surname><given-names>J.</given-names></name><name><surname>Portaels</surname><given-names>F.</given-names></name></person-group><article-title>Resazurinmicrotiter assay plate: Simple and inexpensive method for detection of drug resistance in <italic>Mycobacterium tuberculosis</italic></article-title><source>Antimicrob. Agents Chemother.</source><year>2002</year><volume>46</volume><fpage>2720</fpage><lpage>2722</lpage><pub-id pub-id-type="doi">10.1128/AAC.46.8.2720-2722.2002</pub-id><?supplied-pmid 12121966?><pub-id pub-id-type="pmid">12121966</pub-id></element-citation></ref><ref id="B20-molecules-23-02381"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>CLSI</collab></person-group><source>Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline</source><comment>CLSI Document M26-A</comment><publisher-name>Clinical and Laboratory Standards Institute</publisher-name><publisher-loc>Wayne, PA, USA</publisher-loc><year>1999</year></element-citation></ref><ref id="B21-molecules-23-02381"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didry</surname><given-names>N.</given-names></name><name><surname>Dubreuil</surname><given-names>L.</given-names></name><name><surname>Pinkas</surname><given-names>M.</given-names></name></person-group><article-title>Microbiological Properties of Protoanemonin Isolated from Ranunculus-Bulbosus</article-title><source>Phytother. Res.</source><year>1993</year><volume>7</volume><fpage>21</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1002/ptr.2650070107</pub-id></element-citation></ref><ref id="B22-molecules-23-02381"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadli</surname><given-names>M.</given-names></name><name><surname>Saad</surname><given-names>A.</given-names></name><name><surname>Sayadi</surname><given-names>S.</given-names></name><name><surname>Chevalier</surname><given-names>J.</given-names></name><name><surname>Mezrioui</surname><given-names>N.E.</given-names></name><name><surname>Pages</surname><given-names>J.M.</given-names></name><name><surname>Hassani</surname><given-names>L.</given-names></name></person-group><article-title>Antibacterial activity of <italic>Thymus maroccanus</italic> and <italic>Thymus broussonetii</italic> essential oils against nosocomial infection-bacteria and their synergistic potential with antibiotics</article-title><source>Phytomedicine</source><year>2012</year><volume>19</volume><fpage>464</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.12.003</pub-id><?supplied-pmid 22257599?><pub-id pub-id-type="pmid">22257599</pub-id></element-citation></ref><ref id="B23-molecules-23-02381"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolmas</surname><given-names>J.</given-names></name><name><surname>Pajor</surname><given-names>K.</given-names></name><name><surname>Pajchel</surname><given-names>L.</given-names></name><name><surname>Przekora</surname><given-names>A.</given-names></name><name><surname>Ginalska</surname><given-names>G.</given-names></name><name><surname>Oledzka</surname><given-names>E.</given-names></name><name><surname>Sobczak</surname><given-names>M.</given-names></name></person-group><article-title>Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors</article-title><source>Int. J. Nanomed.</source><year>2017</year><volume>12</volume><fpage>5633</fpage><lpage>5642</lpage><pub-id pub-id-type="doi">10.2147/IJN.S140935</pub-id><?supplied-pmid 28848343?><pub-id pub-id-type="pmid">28848343</pub-id></element-citation></ref><ref id="B24-molecules-23-02381"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>M.W.</given-names></name></person-group><article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title><source>Nucleic Acids Res.</source><year>2001</year><volume>29</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-23-02381-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Relative expression change of <italic>clgR</italic> gene after 1 h exposure to the tested compound, normalized to <italic>sigA</italic> mRNA. Standard deviations were included as the thin bars.</p></caption><graphic xlink:href="molecules-23-02381-g001"/></fig><table-wrap id="molecules-23-02381-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-02381-t001_Table 1</object-id><label>Table 1</label><caption><p>The MIC values of antibiotics, <italic>Cinnamomumverum</italic> EO, cinnamaldehyde, eugnol and linalool determined for <italic>M. tuberculosis</italic> H37Ra.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tested Agent</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MIC (&#x003bc;g/mL)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rifampicin</td><td align="center" valign="middle" rowspan="1" colspan="1">0.002</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" valign="middle" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Isoniazid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Streptomycin</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ethambutol</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Cinnamomumverum</italic> EO</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cinnamaldehyde</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" rowspan="1" colspan="1">256</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Linalool</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;256</td></tr></tbody></table></table-wrap><table-wrap id="molecules-23-02381-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-02381-t002_Table 2</object-id><label>Table 2</label><caption><p>IC<sub>50</sub> and SI values determined for <italic>Cinnamomumverum</italic> EO, cinnamaldehyde, and rifampicin as reference drug.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tested Agent</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MIC (&#x003bc;g/mL)</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub> (&#x003bc;g/mL)</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SI</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1"><italic>Cinnamonumverum</italic> EO</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">69.35 &#x000b1; 1.05</td><td align="center" valign="top" rowspan="1" colspan="1">8.67</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">cinnamaldehyde</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">112.6 &#x000b1; 1.04</td><td align="center" valign="top" rowspan="1" colspan="1">14.08</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">rifampicin</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">170.2 &#x000b1; 2.5</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">85.10</td></tr></tbody></table></table-wrap></floats-group></article>